Exited Investment
WinchPharma developed new and innovative ways to make staying healthy easier, cheaper and more accessible for all stakeholders in both public and private healthcare. Founded in 2011, the management team grew the business primarily within the NHS market, capitalising on Nathan Winch’s background in molecular and cellular biology.
Winch & Co exited the company to Byotrol plc in March 2017, allowing them to enter the NHS market cost-effectively, and providing Winch & Co with a considerable return.
